Isaac A. Kinde, M.D., Ph.D., is Head of Research & Innovation and a Co-Founder of Thrive, where he is commercializing tests for the earlier detection of cancer from a simple blood draw.
As a graduate student at the Johns Hopkins University School of Medicine, his thesis research produced inventions enabling the earlier detection of cancers and other genetic diseases through improvements to massively parallel DNA sequencing technology, under the mentorship of research advisors and co-inventors Drs. Bert Vogelstein, Ken Kinzler, Nickolas Papadopoulos, and Luis Diaz, Jr.
Notable applications of his work include the earlier detection of ovarian and endometrial cancers from liquid-based Pap tests, recurrent bladder cancers from urine, and a variety of cancers from blood. Descriptions of his inventions and their applications appear in prominent scientific journals –such as Proceedings of the National Academy of Sciences, Science, and Nature–and are the subject of several issued patents and patent applications. In 2013, he was recognized as one of Forbes Magazine’s ‘30 under 30’ in Science and Healthcare.
Isaac holds a B.S. from the University of Maryland, Baltimore County, where he was a Meyerhoff Scholar, a Ph.D. in Cellular and Molecular Medicine, and an M.D. from the Johns Hopkins University School of Medicine.
